Most competitors raise the rate when patients move to higher doses, or run a discounted first-month price that more than doubles in month two
Tom Gavin Fact-Checker Tom Gavin joined Everyday Health as copy chief in 2022 after a lengthy stint as a freelance copy editor
Diyet ile beraber kullanyorsanz kahvaltdan 1 saat sonra 1 kapak kullanabilirsiniz
Retatrutide is an investigational medication currently being developed by Eli Lilly for the treatment of obesity and overweight
For example, athletes with high muscle mass may have a high BMI but low body fat, while someone with a normal BMI could still have excess visceral fat
Implications for employers Each year for the past three years, Mercers National Survey of Employer-Sponsored Health Plans has found more large employers (500 or more employees) offering coverage for weight-loss medications, highlighting the importance they place on facilitating access to affordable medication to manage chronic conditions, including obesity